Our Medical Clinic in Los Angeles is specializing in Hepatitis C Trials with drugs in development from
Gilead Sciences, Abbvie and Merck.

Please note: the content of this website is now considered as archived.

We have not updated the information since 2016.

New Hepatitis B Drug Trials in Los Angeles

We are conducting Hepatitis B trials with the following drug companies:

  • Gilead Sciences (Tenofovir alafenamide fumarate (TAF))


Eligible patients must meet the following criteria:

  • 18 years of age or older
  • Documented evidence of chronic Hep B (eg. HBsAg for >6mo or by medical history)
  • E-antigen positive
  • HBV DNA level of 20,000 IU/ML
  • ALT <60 U/L at screening (males) or > 38U/L (female)



Currently Ruane Medical is conducting clinical trials* on new anti-viral compounds targeting Hepatitis B.


Entry into these studies can depend on the specific viral serology of Hepatitis B and the health of the liver, so if a clinical trial is not currently available for your disease state, one could become available in a few months.  


If you would like more information concerning a clinical trial for therapy of Hepatitis B, contact our research institute at 323 - 954 - 0400 or fill out the message form here.



*Clinical trials are research studies that test how new medicines work in people. Each study answers scientific questions and hopes to find better ways to screen for, diagnose, and treat a disease. People who take part in clinical trials have an opportunity to receive new and up-to-date therapy and care from experts. Each clinical trial has a specific plan and rules for who can participate.  




About Ruane Medical

Liver Scan instead of liver biopsy

FDA regulations and information about drug trials

Video to find out more about our location

How to get to our office by car